Refine by
Injectable Drug Articles & Analysis
24 news found
Research institutions focusing on pharmaceutical formulation, cosmetic development, and healthcare solutions will find value in their specialized services, which include: l Advanced Drug Delivery System Development: Targeted drug delivery, injectable formulations, and more. l Pharmaceutical Analytical Methods and Testing Services: Comprehensive ...
CD Formulation is making waves in the pharmaceutical industry with its innovative drug delivery technologies. With a focus on sustained and controlled release formulations, as well as liquid, semi-solid, injectable, and nanoformulations, CD Formulation is at the forefront of the industry's efforts to enhance drug efficacy. ...
This method offers several advantages over traditional oral or injectable routes, including improved drug absorption, reduced side effects, and increased patient compliance. ...
By delivering drugs through the skin, microneedle offers a viable alternative that eliminates the need for injections while ensuring safe and effective drug delivery. ...
Long-Acting Controlled-Release Injection Technologies Another groundbreaking development by CD Formulation is its long-acting controlled-release injection technologies. ...
The newly introduced solutions are focused on long-acting controlled-release microspheres and phase-transition microneedle patches, to meet the growing demand for novel biopharmaceuticals and biosimilars, while at the same time, improving efficacy, safety, and convenience in drug delivery. Microsphere and microneedle technologies have been gaining increasing popularity in ...
The ARAI autoinjector has been developed by Aktiv with the support of BARDA and the Department of Defense (DoD) as a next generation autoinjector platform to address the shortfalls of previous autoinjectors, by improving usability, reliability, robustness, and drug stability. ARAI is a versatile platform that can deliver up to 5 ml dose volumes, perform simultaneous ...
Topical Numbing medications are commonly applied topically. Drugs like lidocaine don’t necessarily need to be injected during simple procedures like skin biopsies. ...
Clearside intends to use the proceeds from the agreement to support ongoing clinical development of its pipeline, including CLS-AX (axitinib injectable suspension) administered by suprachoroidal injection via Clearside’s SCS Microinjector®. ...
“Pharmaceutical formulation development is an indispensable step that makes the new drug substance being discovered gradually develop into a commercial drug product,” commented a senior scientist from CD Formulation. The scientist responsible for drug formulation must determine the most appropriate administration route to achieving ...
Warfighter and emergency medical responders to treat patients in the field as close as possible to the time of injury, with an autoinjector that meets and exceeds the most stringent reliability requirements of the U.S. Food and Drug Administration (FDA) for emergency-use injectors”. The ARAI autoinjector has been developed by Aktiv with the support of the DOD and the U.S. ...
Advancements developed by ApiJect for temperature management now enable BFS manufacturing of a vast array of sterile injectable drugs, including ultra-cold mRNA vaccines. ApiJect Chief Executive Officer Jay Walker commented: “This is an important day for injection device innovation, and, with that, the future health of billions of people ...
(NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today issued a Letter to Shareholders from its Chief Executive Officer, Nadav Kidron. ...
(Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the European Patent Office has granted the Company a patent titled “Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same.” The patent supports ...
Xarelto is the only Factor Xa anticoagulant FDA approved for pediatric patients and offers a flexible weight-based dosing Xarelto is available in both oral tablet and liquid suspension formulations for use in appropriate children less than 18 years of age Convenient liquid formulation advances standard of care for children; alleviates administration challenges found with ...
ByBayer AG
About Redesca™, Redesca HP™ Redesca is a low molecular weight heparin biosimilar. LMWHs are injectable anticoagulant drugs used primarily to treat and prevent deep vein thrombosis and pulmonary embolism. ...
The TALENT study (TALENT) findings, which were presented at the 11th International AIDS Society (IAS) Conference on HIV Science, showed that a two-drug regimen was as effective and safe as multi-drug therapies TALENT is the world's first phase III clinical trial of the new long-acting HIV-1 fusion inhibitor, Aikening® (generic name: Albuvirtide [ABT]) in ...
Thermo Fisher Scientific, the world leader in serving science, today announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines. ...
Revita T2Di pivotal study to evaluate the ability of Revita DMR, the first non-drug, non-surgical, disease-modifying therapy, to eliminate need for insulin injections in T2D; enrollment expected to begin in late 2020 LEXINGTON, Mass., June 3, 2020 — Fractyl Laboratories Inc. ...
Artesunate for Injection 110 mg, powder and solvent for solution is approved by FDA for initial treatment of severe malaria in adult and pediatric patients. Artesunate for Injection is in a group of drugs known as “artemisinin derivatives” and is on the World Health Organization Model List of Essential Medicines. ...